ConductScience.org, home

Paper · 41744673

The Neuro-Bone Axis in Metastatic Progression: Innervation, Neuro-Immune-Osteoclast Crosstalk, and Therapeutic Opportunities.

Bakir M and 6 others. Biology (Basel), 2026. Cited by 4 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. The Neuro-Bone Axis in Metastatic Progression: Innervation, Neuro-Immune-Osteoclast Crosstalk, and Therapeutic Opportunities. Papers, record 41744673. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41744673

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Neuro-Bone Axis in Metastatic Progression: Innervation, Neuro-Immune-Osteoclast Crosstalk, and Therapeutic Opportunities.
PubMed
Journal
Biology (Basel)
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
4
iCite
Revised in PubMed
2026-08-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Bakir MMohamadhttps://orcid.org/0000-0001-8614-5718
2Dabaliz AAlhomamhttps://orcid.org/0009-0009-6963-2878
3Raddaoui MMohammed
4Fatash HHala
5Elsaadany NNourhan
6AlKattan WWael
7Mohammad KSKhalid Saidhttps://orcid.org/0009-0006-9708-2111

Source PubMed

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References206

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
136,589,815The RANK/RANKL/OPG system and tumor bone metastasis: Potential mechanisms and therapeutic strategies.Front Endocrinol (Lausanne)2022https://conductscience.org/library/papers/36589815PubMed
218,487,245Assessment of pain.Br J Anaesth2008https://conductscience.org/library/papers/18487245PubMed
337,532,929Pharmacological targeting of netrin-1 inhibits EMT in cancer.Nature2023https://conductscience.org/library/papers/37532929PubMed
424,952,646Chronic variable stress activates hematopoietic stem cells.Nat Med2014https://conductscience.org/library/papers/24952646PubMed
533,334,813Cancer-Associated Neurogenesis and Nerve-Cancer Cross-talk.Cancer Res2021https://conductscience.org/library/papers/33334813PubMed
637,371,563Carcinogenesis and Metastasis: Focus on TRPV1-Positive Neurons and Immune Cells.Biomolecules2023https://conductscience.org/library/papers/37371563PubMed
738,988,156Unveiling the Promising Role of Substance P/Neurokinin 1 Receptor in Cancer Cell Proliferation and Cell Cycle Regulation in Human Malignancies.Curr Med Chem2025https://conductscience.org/library/papers/38988156PubMed
824,792,411Bone cancer pain: from mechanism to therapy.Curr Opin Support Palliat Care2014https://conductscience.org/library/papers/24792411PubMed
939,125,732Balancing the Scales: The Dual Role of Interleukins in Bone Metastatic Microenvironments.Int J Mol Sci2024https://conductscience.org/library/papers/39125732PubMed
1034,469,219Bone Metastases: State of the Art in Minimally Invasive Interventional Oncology.Radiographics2021https://conductscience.org/library/papers/34469219PubMed

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.

PMIDTitleJournalYearIn PapersSource
42,707,465Sympathetic regulation of bone homeostasis and remodeling: molecular mechanisms, pathophysiological roles, and therapeutic implications.Front Immunol2026https://conductscience.org/library/papers/42707465PubMed
42,591,546Modeling and targeting the hostile physicochemical niche in bone metastasis: from experimental platforms to niche-directed therapy.Front Cell Dev Biol2026https://conductscience.org/library/papers/42591546PubMed
42,548,817Neuroimmune regulation of post-traumatic bone regeneration: focus on inflammatory switching and functional recovery.Front Immunol2026https://conductscience.org/library/papers/42548817PubMed
42,198,265Nanoparticle Strategies for Bone Metastasis Immunotherapy: Targeting, Immune Reprogramming and Combination Therapy.Pharmaceutics2026https://conductscience.org/library/papers/42198265PubMed

Genes85

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41744673

GET https://conductscience.org/api/papers/v1/41744673/references?page=2